and CAR T cell therapeutics. Such work is a testament to Sphere Fluidics’ commitment to expanding the use of the Cyto-Mine technology. Having developed a platform that makes biopharmaceutical ...

The combination of Cyto-Cellect ® PLUS and Cyto-Mine ® provides a test for measuring single-cell productivity by immediately identifying secreted IgG, allowing cells with the highest ...

Sphere Bio, a leading provider of innovative picodroplet-based microfluidics solutions for functional single-cell analysis and isolation, today announced the launch of the Cyto-Cellect® Human IgG ...

In a year marked by significant volatility, CYTO stock has reached a new 52-week low, trading at $0.45. This latest price level reflects a stark downturn for the company, which has seen its shares ...

Cytek Biosciences, Inc. is highlighting its Full Spectrum Profiling™ (FSP®) technology at the upcoming CYTO 2025 and IMMUNOLOGY2025 conferences to promote advancements in cell analysis.

At CYTO, Cytek, a Platinum sponsor of the conference, will showcase its technology, designed to accelerate scientific discovery. Built with the scientist in mind, Cytek’s solutions continually ...